|
All
(n=86)
|
Group A
(n=25)
|
Group B
(n=61)
|
|
Male sex |
50 (58) |
17 (68) |
33 (54) |
0.34 |
Age [years], median(IQR) |
64 (54-69) |
67 (60-71) |
62 (53-68) |
0.046 |
NYHA class
NYHA I
NYHA II
NYHA III
NYHA IV
|
27 (31)
46 (54)
10 (12)
3 (3.5)
|
7 (28)
13 (52)
2 (8.0)
3 (12)
|
20 (33)
33 (54)
8 (13)
0
|
0.049
|
Previous cardiac surgery |
15 (17) |
3 (12) |
12 (20) |
0.54 |
Chronic aortic dissection |
30 (35) |
11 (44) |
19 (31) |
0.32 |
Aortic root aneurysm |
13 (15) |
2 (8.0) |
11 (18) |
0.33 |
Ascending aorta aneurysm |
70 (81) |
21 (84) |
49 (80) |
0.77 |
Descending aorta aneurysm |
33 (38) |
6 (24) |
27 (44) |
0.09 |
Saccular aortic arch aneurysm |
3 (3.5) |
2 (8.0) |
1 (1.6) |
0.20 |
Arterial hypertension |
65 (78) |
20 (90.9) |
45 (74) |
0.13 |
Coronary artery disease |
18 (21) |
6 (24) |
12 (20) |
0.77 |
Mitral valve regurgitation
No
Trace
Mild
Moderate
Severe
|
(n=68)
12 (18)
26 (38)
19 (28)
7 (10)
4 (5.9)
|
(n=7)
0
5 (71)
1 (14)
0
1 (14)
|
(n=61)
12 (20)
21 (34)
18 (30)
7 (12)
3 (4.9)
|
0.21
|
Tricuspid valve regurgitation
No
Trace
Mild
Moderate
Severe
|
(n=68)
22 (32)
19 (28)
19 (28)
6 (8.8)
2 (2.9)
|
(n=7)
2 (29)
3 (43)
1 (14)
1 (14)
0
|
(n=61)
20 (33)
16 (26)
18 (30)
5 (8.2)
2 (3.3)
|
0.80
|
Renal function
Normal (GFR>85ml/min/1.73m2)
Moderately impaired [GFR 50-85ml/min/1.73m2]
Severely impaired [GFR<35ml/min/1.73m2]
Dialysis
|
50 (58)
28 (33)
7 (8.1)
1 (1.2)
|
12 (48)
8 (32)
4 (16)
1 (4.0)
|
38 (62)
20 (33)
3 (4.9)
0
|
0.13
|
Diabetes (n=83)
|
9 (11)
|
4 (18)
(n=22)
|
5 (8.2)
(n=61)
|
0.24
|
BMI [kg/m2], median(IQR) |
27 (24-30) |
28 (25-30) |
26 (24-30) |
0.25 |
Serum creatinine [mg/dl], median(IQR) |
0.87 (0.74-1.08) |
1.02
(0.79-1.37) |
0.82 (0.70-1.00) |
0.004 |
EF [%], median (IQR), (n=85) |
55 (50-60) |
50 (45-60) |
55 (50-60) |
0.06 |
EUROSCORE II, median (IQR) |
4.98 (3.01-8.89) |
4.29 (2.82-8.39) |
5.34
(3.23-9.15) |
0.42 |